{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:44:42Z","timestamp":1782607482961,"version":"3.54.5"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"42","license":[{"start":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T00:00:00Z","timestamp":1422835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/onc.2014.450","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T11:11:13Z","timestamp":1422875473000},"page":"5341-5351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Hedgehog\/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia"],"prefix":"10.1038","volume":"34","author":[{"given":"D","family":"Kern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Regl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S W","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Altenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Achatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Dlugosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Schnidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Greil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T N","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Aberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,2]]},"reference":[{"key":"BFonc2014450_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature03100","volume":"432","author":"PA Beachy","year":"2004","unstructured":"Beachy PA, Karhadkar SS, Berman DM . Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432: 324\u2013331.","journal-title":"Nature"},{"key":"BFonc2014450_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrc2503","volume":"8","author":"EH Epstein","year":"2008","unstructured":"Epstein EH . Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008; 8: 743\u2013754.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2014450_CR3","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/j.psyneuen.2007.03.017","volume":"32","author":"A Gulino","year":"2007","unstructured":"Gulino A, Di Marcotullio L, Ferretti E, De Smaele E, Screpanti I . Hedgehog signaling pathway in neural development and disease. Psychoneuroendocrinology 2007; 32: S52\u2013S56.","journal-title":"Psychoneuroendocrinology"},{"key":"BFonc2014450_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.tips.2009.03.007","volume":"30","author":"SJ Scales","year":"2009","unstructured":"Scales SJ, de Sauvage FJ . Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci 2009; 30: 303\u2013312.","journal-title":"Trends Pharmacol Sci"},{"key":"BFonc2014450_CR5","first-page":"181","volume":"1805","author":"S Teglund","year":"2010","unstructured":"Teglund S, Toftgard R . Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim Biophys Acta 2010; 1805: 181\u2013208.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc2014450_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/B978-0-12-394622-5.00002-X","volume":"88","author":"F Aberger","year":"2012","unstructured":"Aberger F, Kern D, Greil R, Hartmann TN . Canonical and noncanonical Hedgehog\/GLI signaling in hematological malignancies. Vitam Horm 2012; 88: 25\u201354.","journal-title":"Vitam Horm"},{"key":"BFonc2014450_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.semcdb.2014.05.003","volume":"33","author":"F Aberger","year":"2014","unstructured":"Aberger F, Ruiz i Altaba A. Context-dependent signal integration by the GLI code: the oncogenic load, pathways, modifiers and implications for cancer therapy. Semin Cell Dev Biol 2014; 33: 93\u2013104.","journal-title":"Semin Cell Dev Biol"},{"key":"BFonc2014450_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/B978-0-12-394622-5.00003-1","volume":"88","author":"D Brennan","year":"2012","unstructured":"Brennan D, Chen X, Cheng L, Mahoney M, Riobo NA . Noncanonical Hedgehog signaling. Vitam Horm 2012; 88: 55\u201372.","journal-title":"Vitam Horm"},{"key":"BFonc2014450_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nrm1622","volume":"6","author":"JE Hooper","year":"2005","unstructured":"Hooper JE, Scott MP . Communicating with Hedgehogs. Nat Rev Mol Cell Biol 2005; 6: 306\u2013317.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2014450_CR10","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1101\/gad.938601","volume":"15","author":"PW Ingham","year":"2001","unstructured":"Ingham PW, McMahon AP . Hedgehog signaling in animal development: paradigms and principles. Genes Dev 2001; 15: 3059\u20133087.","journal-title":"Genes Dev"},{"key":"BFonc2014450_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrg2984","volume":"12","author":"PW Ingham","year":"2011","unstructured":"Ingham PW, Nakano Y, Seger C . Mechanisms and functions of Hedgehog signalling across the metazoa. Nat Rev Genet 2011; 12: 393\u2013406.","journal-title":"Nat Rev Genet"},{"key":"BFonc2014450_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2741\/3917","volume":"17","author":"D Mangelberger","year":"2012","unstructured":"Mangelberger D, Kern D, Loipetzberger A, Eberl M, Aberger F . Cooperative Hedgehog-EGFR signaling. Front Biosci 2012; 17: 90\u201399.","journal-title":"Front Biosci"},{"key":"BFonc2014450_CR13","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/ncb435","volume":"9","author":"R Rohatgi","year":"2007","unstructured":"Rohatgi R, Scott MP . Patching the gaps in Hedgehog signalling. Nat Cell Biol 2007; 9: 1005\u20131009.","journal-title":"Nat Cell Biol"},{"key":"BFonc2014450_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/jmcb\/mjp052","volume":"2","author":"B Stecca","year":"2010","unstructured":"Stecca B, Ruiz IAA . Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. J Mol Cell Biol 2010; 2: 84\u201395.","journal-title":"J Mol Cell Biol"},{"key":"BFonc2014450_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev-cellbio-092910-154048","volume":"27","author":"CC Hui","year":"2011","unstructured":"Hui CC, Angers S . Gli proteins in development and disease. Annu Rev Cell Dev Biol 2011; 27: 513\u2013537.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"BFonc2014450_CR16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tcb.2007.06.007","volume":"17","author":"A Ruiz i Altaba","year":"2007","unstructured":"Ruiz i Altaba A, Mas C, Stecca B . The Gli code: an information nexus regulating cell fate, stemness and cancer. Trends Cell Biol 2007; 17: 438\u2013447.","journal-title":"Trends Cell Biol"},{"key":"BFonc2014450_CR17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature11889","volume":"494","author":"SX Atwood","year":"2013","unstructured":"Atwood SX, Li M, Lee A, Tang JY, Oro AE . GLI activation by atypical protein kinase C iota\/lambda regulates the growth of basal cell carcinomas. Nature 2013; 494: 484\u2013488.","journal-title":"Nature"},{"key":"BFonc2014450_CR18","doi-asserted-by":"publisher","first-page":"9074","DOI":"10.1074\/jbc.M806233200","volume":"284","author":"E Beauchamp","year":"2009","unstructured":"Beauchamp E, Bulut G, Abaan O, Chen K, Merchant A, Matsui W et al. GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein. J Biol Chem 2009; 284: 9074\u20139082.","journal-title":"J Biol Chem"},{"key":"BFonc2014450_CR19","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.1158\/0008-5472.CAN-07-0491","volume":"67","author":"S Dennler","year":"2007","unstructured":"Dennler S, Andre J, Alexaki I, Li A, Magnaldo T, ten Dijke P et al. Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res 2007; 67: 6981\u20136986.","journal-title":"Cancer Res"},{"key":"BFonc2014450_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1101\/gad.1753809","volume":"23","author":"O Nolan-Stevaux","year":"2009","unstructured":"Nolan-Stevaux O, Lau J, Truitt ML, Chu GC, Hebrok M, Fernandez-Zapico ME et al. GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev 2009; 23: 24\u201336.","journal-title":"Genes Dev"},{"key":"BFonc2014450_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/emmm.201100201","volume":"4","author":"M Eberl","year":"2012","unstructured":"Eberl M, Klingler S, Mangelberger D, Loipetzberger A, Damhofer H, Zoidl K et al. Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells. EMBO Mol Med 2012; 4: 218\u2013233.","journal-title":"EMBO Mol Med"},{"key":"BFonc2014450_CR22","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1128\/MCB.02317-05","volume":"26","author":"M Kasper","year":"2006","unstructured":"Kasper M, Schnidar H, Neill GW, Hanneder M, Klingler S, Blaas L et al. Selective modulation of Hedgehog\/GLI target gene expression by epidermal growth factor signaling in human keratinocytes. Mol Cell Biol 2006; 26: 6283\u20136298.","journal-title":"Mol Cell Biol"},{"key":"BFonc2014450_CR23","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1038\/sj.onc.1210321","volume":"26","author":"M Lauth","year":"2007","unstructured":"Lauth M, Bergstrom A, Toftgard R . Phorbol esters inhibit the Hedgehog signalling pathway downstream of Suppressor of Fused, but upstream of Gli. Oncogene 2007; 26: 5163\u20135168.","journal-title":"Oncogene"},{"key":"BFonc2014450_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.gastro.2012.09.061","volume":"144","author":"P Pelczar","year":"2013","unstructured":"Pelczar P, Zibat A, van Dop WA, Heijmans J, Bleckmann A, Gruber W et al. Inactivation of Patched1 in mice leads to development of gastrointestinal stromal-like tumors that express Pdgfralpha but not kit. Gastroenterology 2013; 144: 134\u2013144 e136.","journal-title":"Gastroenterology"},{"key":"BFonc2014450_CR25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1158\/0008-5472.CAN-05-2539","volume":"66","author":"NA Riobo","year":"2006","unstructured":"Riobo NA, Haines GM, Emerson CP Jr . Protein kinase C-delta and mitogen-activated protein\/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling. Cancer Res 2006; 66: 839\u2013845.","journal-title":"Cancer Res"},{"key":"BFonc2014450_CR26","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1073\/pnas.0504337103","volume":"103","author":"NA Riobo","year":"2006","unstructured":"Riobo NA, Lu K, Ai X, Haines GM, Emerson CP Jr . Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. Proc Natl Acad Sci USA 2006; 103: 4505\u20134510.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014450_CR27","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/0008-5472.CAN-08-2331","volume":"69","author":"H Schnidar","year":"2009","unstructured":"Schnidar H, Eberl M, Klingler S, Mangelberger D, Kasper M, Hauser-Kronberger C et al. Epidermal growth factor receptor signaling synergizes with Hedgehog\/GLI in oncogenic transformation via activation of the MEK\/ERK\/JUN pathway. Cancer Res 2009; 69: 1284\u20131292.","journal-title":"Cancer Res"},{"key":"BFonc2014450_CR28","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1073\/pnas.0700776104","volume":"104","author":"B Stecca","year":"2007","unstructured":"Stecca B, Mas C, Clement V, Zbinden M, Correa R, Piguet V et al. Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK\/AKT pathways. Proc Natl Acad Sci USA 2007; 104: 5895\u20135900.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014450_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccr.2011.12.028","volume":"21","author":"Y Wang","year":"2012","unstructured":"Wang Y, Ding Q, Yen CJ, Xia W, Izzo JG, Lang JY et al. The cross-talk of mTOR\/S6K1 and Hedgehog pathways. Cancer Cell 2012; 21: 374\u2013387.","journal-title":"Cancer Cell"},{"key":"BFonc2014450_CR30","doi-asserted-by":"publisher","first-page":"51ra70","DOI":"10.1126\/scitranslmed.3001599","volume":"2","author":"S Buonamici","year":"2010","unstructured":"Buonamici S, Williams J, Morrissey M, Wang A, Guo R, Vattay A et al. Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci Transl Med 2010; 2: 51ra70.","journal-title":"Sci Transl Med"},{"key":"BFonc2014450_CR31","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/nm.3328","volume":"19","author":"M Gruber Filbin","year":"2013","unstructured":"Gruber Filbin M, Dabral SK, Pazyra-Murphy MF, Ramkissoon S, Kung AL, Pak E et al. Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities. Nat Med 2013; 19: 1518\u20131523.","journal-title":"Nat Med"},{"key":"BFonc2014450_CR32","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1158\/1078-0432.CCR-12-3934","volume":"19","author":"KH Dao","year":"2013","unstructured":"Dao KH, Tyner JW . Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies. Clin Cancer Res 2013; 19: 1309\u20131311.","journal-title":"Clin Cancer Res"},{"key":"BFonc2014450_CR33","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1182\/blood-2011-06-359075","volume":"119","author":"S Decker","year":"2012","unstructured":"Decker S, Zirlik K, Djebatchie L, Hartmann D, Ihorst G, Schmitt-Graeff A et al. Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL. Blood 2012; 119: 997\u20131007.","journal-title":"Blood"},{"key":"BFonc2014450_CR34","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nm1614","volume":"13","author":"C Dierks","year":"2007","unstructured":"Dierks C, Grbic J, Zirlik K, Beigi R, Englund NP, Guo GR et al. Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med 2007; 13: 944\u2013951.","journal-title":"Nat Med"},{"key":"BFonc2014450_CR35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","volume":"14","author":"C Dierks","year":"2008","unstructured":"Dierks C, Beigi R, Guo GR, Zirlik K, Stegert MR, Manley P et al. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 2008; 14: 238\u2013249.","journal-title":"Cancer Cell"},{"key":"BFonc2014450_CR36","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1158\/1078-0432.CCR-12-1777","volume":"19","author":"S Katagiri","year":"2013","unstructured":"Katagiri S, Tauchi T, Okabe S, Minami Y, Kimura S, Maekawa T et al. Combination of ponatinib with Hedgehog antagonist vismodegib for therapy-resistant BCR-ABL1-positive leukemia. Clin Cancer Res 2013; 19: 1422\u20131432.","journal-title":"Clin Cancer Res"},{"key":"BFonc2014450_CR37","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2009-09-241703","volume":"115","author":"A Merchant","year":"2010","unstructured":"Merchant A, Joseph G, Wang Q, Brennan S, Matsui W . Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. Blood 2010; 115: 2391\u20132396.","journal-title":"Blood"},{"key":"BFonc2014450_CR38","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1073\/pnas.0611682104","volume":"104","author":"CD Peacock","year":"2007","unstructured":"Peacock CD, Wang Q, Gesell GS, Corcoran-Schwartz IM, Jones E, Kim J et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci USA 2007; 104: 4048\u20134053.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014450_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature13283","volume":"511","author":"HA Zahreddine","year":"2014","unstructured":"Zahreddine HA, Culjkovic-Kraljacic B, Assouline S, Gendron P, Romeo AA, Morris SJ et al. The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation. Nature 2014; 511: 90\u201393.","journal-title":"Nature"},{"key":"BFonc2014450_CR40","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nature07737","volume":"458","author":"C Zhao","year":"2009","unstructured":"Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009; 458: 776\u2013779.","journal-title":"Nature"},{"key":"BFonc2014450_CR41","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1038\/onc.2010.243","volume":"29","author":"P Desch","year":"2010","unstructured":"Desch P, Asslaber D, Kern D, Schnidar H, Mangelberger D, Alinger B et al. Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells. Oncogene 2010; 29: 4885\u20134895.","journal-title":"Oncogene"},{"key":"BFonc2014450_CR42","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1158\/1541-7786.MCR-08-0142","volume":"6","author":"GV Hegde","year":"2008","unstructured":"Hegde GV, Peterson KJ, Emanuel K, Mittal AK, Joshi AD, Dickinson JD et al. Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. Mol Cancer Res 2008; 6: 1928\u20131936.","journal-title":"Mol Cancer Res"},{"key":"BFonc2014450_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nrclinonc.2009.72","volume":"6","author":"L Pleyer","year":"2009","unstructured":"Pleyer L, Egle A, Hartmann TN, Greil R . Molecular and cellular mechanisms of CLL: novel therapeutic approaches. Nat Rev Clin Oncol 2009; 6: 405\u2013418.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFonc2014450_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrc2764","volume":"10","author":"T Zenz","year":"2010","unstructured":"Zenz T, Mertens D, Kuppers R, Dohner H, Stilgenbauer S . From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer 2010; 10: 37\u201350.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2014450_CR45","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","volume":"114","author":"JA Burger","year":"2009","unstructured":"Burger JA, Ghia P, Rosenwald A, Caligaris-Cappio F . The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood 2009; 114: 3367\u20133375.","journal-title":"Blood"},{"key":"BFonc2014450_CR46","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1182\/blood-2011-06-338855","volume":"118","author":"FK Stevenson","year":"2011","unstructured":"Stevenson FK, Krysov S, Davies AJ, Steele AJ, Packham G . B-cell receptor signaling in chronic lymphocytic leukemia. Blood 2011; 118: 4313\u20134320.","journal-title":"Blood"},{"key":"BFonc2014450_CR47","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa1315226","volume":"370","author":"RR Furman","year":"2014","unstructured":"Furman RR, Sharman JP, Coutre SE, Cheson BD, Pagel JM, Hillmen P et al. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. N Engl J Med 2014; 370: 997\u20131007.","journal-title":"N Engl J Med"},{"key":"BFonc2014450_CR48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1756-8722-6-36","volume":"6","author":"M Wu","year":"2013","unstructured":"Wu M, Akinleye A, Zhu X . Novel agents for chronic lymphocytic leukemia. J Hematol Oncol 2013; 6: 36.","journal-title":"J Hematol Oncol"},{"key":"BFonc2014450_CR49","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/cncr.20773","volume":"103","author":"AM Tsimberidou","year":"2005","unstructured":"Tsimberidou AM, Keating MJ . Richter syndrome: biology, incidence, and therapeutic strategies. Cancer 2005; 103: 216\u2013228.","journal-title":"Cancer"},{"key":"BFonc2014450_CR50","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood-2013-11-535047","volume":"123","author":"JR Brown","year":"2014","unstructured":"Brown JR, Byrd JC, Coutre SE, Benson DM, Flinn IW, Wagner-Johnston ND et al. Idelalisib, an inhibitor of phosphatidylinositol 3 kinase p110delta, for relapsed\/refractory chronic lymphocytic leukemia. Blood 2014; 123: 3390\u20133397.","journal-title":"Blood"},{"key":"BFonc2014450_CR51","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1073\/pnas.102181599","volume":"99","author":"R Bichi","year":"2002","unstructured":"Bichi R, Shinton SA, Martin ES, Koval A, Calin GA, Cesari R et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 2002; 99: 6955\u20136960.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014450_CR52","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1093\/emboj\/cdg271","volume":"22","author":"V Grachtchouk","year":"2003","unstructured":"Grachtchouk V, Grachtchouk M, Lowe L, Johnson T, Wei L, Wang A et al. The magnitude of hedgehog signaling activity defines skin tumor phenotype. Embo J 2003; 22: 2741\u20132751.","journal-title":"Embo J"},{"key":"BFonc2014450_CR53","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nature04117","volume":"437","author":"KC Corbit","year":"2005","unstructured":"Corbit KC, Aanstad P, Singla V, Norman AR, Stainier DY, Reiter JF . Vertebrate Smoothened functions at the primary cilium. Nature 2005; 437: 1018\u20131021.","journal-title":"Nature"},{"key":"BFonc2014450_CR54","doi-asserted-by":"publisher","first-page":"11325","DOI":"10.1073\/pnas.0505328102","volume":"102","author":"D Huangfu","year":"2005","unstructured":"Huangfu D, Anderson KV . Cilia and Hedgehog responsiveness in the mouse. Proc Natl Acad Sci USA 2005; 102: 11325\u201311330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014450_CR55","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1126\/science.1139740","volume":"317","author":"R Rohatgi","year":"2007","unstructured":"Rohatgi R, Milenkovic L, Scott MP . Patched1 regulates hedgehog signaling at the primary cilium. Science 2007; 317: 372\u2013376.","journal-title":"Science"},{"key":"BFonc2014450_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.it.2011.02.001","volume":"32","author":"F Finetti","year":"2011","unstructured":"Finetti F, Paccani SR, Rosenbaum J, Baldari CT . Intraflagellar transport: a new player at the immune synapse. Trends Immunol 2011; 32: 139\u2013145.","journal-title":"Trends Immunol"},{"key":"BFonc2014450_CR57","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1101\/gad.1470806","volume":"20","author":"M Pasca di Magliano","year":"2006","unstructured":"Pasca di Magliano M, Sekine S, Ermilov A, Ferris J, Dlugosz AA, Hebrok M . Hedgehog\/Ras interactions regulate early stages of pancreatic cancer. Genes Dev 2006; 20: 3161\u20133173.","journal-title":"Genes Dev"},{"key":"BFonc2014450_CR58","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1084\/jem.20021101","volume":"197","author":"A Suzuki","year":"2003","unstructured":"Suzuki A, Kaisho T, Ohishi M, Tsukio-Yamaguchi M, Tsubata T, Koni PA et al. Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J Exp Med 2003; 197: 657\u2013667.","journal-title":"J Exp Med"},{"key":"BFonc2014450_CR59","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1476-4598-8-40","volume":"8","author":"B Ju","year":"2009","unstructured":"Ju B, Spitsbergen J, Eden CJ, Taylor MR, Chen W . Co-activation of hedgehog and AKT pathways promote tumorigenesis in zebrafish. Mol Cancer 2009; 8: 40.","journal-title":"Mol Cancer"},{"key":"BFonc2014450_CR60","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0145-2126(98)00154-4","volume":"23","author":"A Stacchini","year":"1999","unstructured":"Stacchini A, Aragno M, Vallario A, Alfarano A, Circosta P, Gottardi D et al. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res 1999; 23: 127\u2013136.","journal-title":"Leuk Res"},{"key":"BFonc2014450_CR61","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1021\/jm800295d","volume":"51","author":"AJ Folkes","year":"2008","unstructured":"Folkes AJ, Ahmadi K, Alderton WK, Alix S, Baker SJ, Box G et al. The identification of 2-(1\u2009H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-t hieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer. J Med Chem 2008; 51: 5522\u20135532.","journal-title":"J Med Chem"},{"key":"BFonc2014450_CR62","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","volume":"7","author":"SM Maira","year":"2008","unstructured":"Maira SM, Stauffer F, Brueggen J, Furet P, Schnell C, Fritsch C et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther 2008; 7: 1851\u20131863.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2014450_CR63","doi-asserted-by":"publisher","first-page":"8455","DOI":"10.1073\/pnas.0609699104","volume":"104","author":"M Lauth","year":"2007","unstructured":"Lauth M, Bergstrom A, Shimokawa T, Toftgard R . Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA 2007; 104: 8455\u20138460.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014450_CR64","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj2960297","volume":"296","author":"A Arcaro","year":"1993","unstructured":"Arcaro A, Wymann MP . Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem J 1993; 296: 297\u2013301.","journal-title":"Biochem J"},{"key":"BFonc2014450_CR65","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/369756a0","volume":"369","author":"EJ Brown","year":"1994","unstructured":"Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 1994; 369: 756\u2013758.","journal-title":"Nature"},{"key":"BFonc2014450_CR66","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJMoa0902903","volume":"361","author":"CM Rudin","year":"2009","unstructured":"Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009; 361: 1173\u20131178.","journal-title":"N Engl J Med"},{"key":"BFonc2014450_CR67","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","volume":"366","author":"A Sekulic","year":"2012","unstructured":"Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012; 366: 2171\u20132179.","journal-title":"N Engl J Med"},{"key":"BFonc2014450_CR68","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/jid.2011.48","volume":"131","author":"H Skvara","year":"2011","unstructured":"Skvara H, Kalthoff F, Meingassner JG, Wolff-Winiski B, Aschauer H, Kelleher JF et al. Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor. J Invest Dermatol 2011; 131: 1735\u20131744.","journal-title":"J Invest Dermatol"},{"key":"BFonc2014450_CR69","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1056\/NEJMoa1113538","volume":"366","author":"JY Tang","year":"2012","unstructured":"Tang JY, Mackay-Wiggan JM, Aszterbaum M, Yauch RL, Lindgren J, Chang K et al. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 2012; 366: 2180\u20132188.","journal-title":"N Engl J Med"},{"key":"BFonc2014450_CR70","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1056\/NEJMoa0905360","volume":"361","author":"DD Von Hoff","year":"2009","unstructured":"Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009; 361: 1164\u20131172.","journal-title":"N Engl J Med"},{"key":"BFonc2014450_CR71","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.1179386","volume":"326","author":"RL Yauch","year":"2009","unstructured":"Yauch RL, Dijkgraaf GJ, Alicke B, Januario T, Ahn CP, Holcomb T et al. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 2009; 326: 572\u2013574.","journal-title":"Science"},{"key":"BFonc2014450_CR72","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/modpathol.2009.98","volume":"22","author":"JE Kim","year":"2009","unstructured":"Kim JE, Singh RR, Cho-Vega JH, Drakos E, Davuluri Y, Khokhar FA et al. Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma. Mod Pathol 2009; 22: 1312\u20131320.","journal-title":"Mod Pathol"},{"key":"BFonc2014450_CR73","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S1471-4906(03)00022-X","volume":"24","author":"MR Gold","year":"2003","unstructured":"Gold MR . Akt is TCL-ish: implications for B-cell lymphoma. Trend Immunol 2003; 24: 104\u2013108.","journal-title":"Trend Immunol"},{"key":"BFonc2014450_CR74","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3324\/haematol.2008.004028","volume":"94","author":"M de Frias","year":"2009","unstructured":"de Frias M, Iglesias-Serret D, Cosialls AM, Coll-Mulet L, Santidrian AF, Gonzalez-Girones DM et al. Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Haematologica 2009; 94: 1698\u20131707.","journal-title":"Haematologica"},{"key":"BFonc2014450_CR75","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1182\/blood-2010-02-271171","volume":"116","author":"SE Herman","year":"2010","unstructured":"Herman SE, Gordon AL, Wagner AJ, Heerema NA, Zhao W, Flynn JM et al. Phosphatidylinositol 3-kinase-delta inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals. Blood 2010; 116: 2078\u20132088.","journal-title":"Blood"},{"key":"BFonc2014450_CR76","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJM199811053391901","volume":"339","author":"SL Soignet","year":"1998","unstructured":"Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998; 339: 1341\u20131348.","journal-title":"N Engl J Med"},{"key":"BFonc2014450_CR77","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00109-008-0314-6","volume":"86","author":"O Merkel","year":"2008","unstructured":"Merkel O, Heyder C, Asslaber D, Hamacher F, Tinhofer I, Holler C et al. Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13. J Mol Med (Berl) 2008; 86: 541\u2013552.","journal-title":"J Mol Med (Berl)"},{"key":"BFonc2014450_CR78","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1172\/JCI42874","volume":"121","author":"EM Beauchamp","year":"2011","unstructured":"Beauchamp EM, Ringer L, Bulut G, Sajwan KP, Hall MD, Lee YC et al. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog\/GLI pathway. J Clin Invest 2011; 121: 148\u2013160.","journal-title":"J Clin Invest"},{"key":"BFonc2014450_CR79","doi-asserted-by":"publisher","first-page":"13432","DOI":"10.1073\/pnas.1006822107","volume":"107","author":"J Kim","year":"2010","unstructured":"Kim J, Lee JJ, Gardner D, Beachy PA . Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector. Proc Natl Acad Sci USA 2010; 107: 13432\u201313437.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014450_CR80","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1158\/1535-7163.MCT-07-2164","volume":"7","author":"KK Mann","year":"2008","unstructured":"Mann KK, Colombo M, Miller WH Jr. . Arsenic trioxide decreases AKT protein in a caspase-dependent manner. Mol Cancer Ther 2008; 7: 1680\u20131687.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2014450_CR81","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.bbrc.2011.03.024","volume":"407","author":"P Xue","year":"2011","unstructured":"Xue P, Hou Y, Zhang Q, Woods CG, Yarborough K, Liu H et al. Prolonged inorganic arsenite exposure suppresses insulin-stimulated AKT S473 phosphorylation and glucose uptake in 3T3-L1 adipocytes: involvement of the adaptive antioxidant response. Biochem Biophys Res Commun 2011; 407: 360\u2013365.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2014450_CR82","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/nar\/25.6.1317","volume":"25","author":"RC Rickert","year":"1997","unstructured":"Rickert RC, Roes J, Rajewsky K . B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acid Res 1997; 25: 1317\u20131318.","journal-title":"Nucleic Acid Res"},{"key":"BFonc2014450_CR83","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1101\/gad.1190304","volume":"18","author":"J Jeong","year":"2004","unstructured":"Jeong J, Mao J, Tenzen T, Kottmann AH, McMahon AP . Hedgehog signaling in the neural crest cells regulates the patterning and growth of facial primordia. Genes Dev 2004; 18: 937\u2013951.","journal-title":"Genes Dev"},{"key":"BFonc2014450_CR84","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S1074-7613(01)00134-0","volume":"14","author":"A Suzuki","year":"2001","unstructured":"Suzuki A, Yamaguchi MT, Ohteki T, Sasaki T, Kaisho T, Kimura Y et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 2001; 14: 523\u2013534.","journal-title":"Immunity"},{"key":"BFonc2014450_CR85","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-1-59745-516-9_6","volume":"397","author":"M Kasper","year":"2007","unstructured":"Kasper M, Regl G, Eichberger T, Frischauf AM, Aberger F . Efficient manipulation of Hedgehog\/GLI signaling using retroviral expression systems. Methods Mol Biol 2007; 397: 67\u201378.","journal-title":"Methods Mol Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/onc2014450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2014450","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2014450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:58:06Z","timestamp":1684472286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2014450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,2]]},"references-count":85,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFonc2014450"],"URL":"https:\/\/doi.org\/10.1038\/onc.2014.450","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,2]]},"assertion":[{"value":"12 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}